Document is current
Any future updates will be listed below
-
Authors
Huber, Kim Lien
Himmel, Dorota
Steiner, Irene
Jeremic, Natasa
Widmann-Sedlnitzky, Paul
Stino, Heiko https://orcid.org/0000-0003-0233-359X
Kunze, Laura
Reiter, Gregor S. https://orcid.org/0000-0001-7661-4015
Schmidt-Erfurth, Ursula https://orcid.org/0000-0002-7788-7311
Pollreisz, Andreas https://orcid.org/0000-0003-3902-239X
- License Information
-
More Information
Article History
Received: 8 August 2025
Revised: 11 February 2026
Accepted: 13 February 2026
First Online: 3 March 2026
Competing interests
: KLH, None; DH, None; IS, None; NJ, None; PW-S, None; HS received financial support from Roche and AbbVie. GSR is a consultant for Apellis, Bayer, Boehringer Ingelheim, Espansione, Nordic Pharma and Roche and received financial support from RetInSight; US-E is a consultant for and received financial support from Appelis and AbbVie, receives financial support from Alcon and is a consultant for Bayer, Medscape, Allergan, Roche, Boehringer, Aviceda, Annexon, Topcon, Alkeus, Genentech, Kodiak, RetInSight, Apellis Pharmaceuticals and Novartis; AP is a consultant for Allergan, Bayer, Roche and Oertli Instruments.
